Loading…

Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience

Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma. Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST. Settings and Design: This was a retrospective study. Subjects and Methods: Ninety...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and therapeutics 2021-01, Vol.17 (1), p.106-113
Main Authors: Sharma, Mohit, Puj, Ketul, Salunke, Abhijeet, Pandya, Shashank, Gandhi, Jahnavi, Parikh, Ankita
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593
cites cdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593
container_end_page 113
container_issue 1
container_start_page 106
container_title Journal of cancer research and therapeutics
container_volume 17
creator Sharma, Mohit
Puj, Ketul
Salunke, Abhijeet
Pandya, Shashank
Gandhi, Jahnavi
Parikh, Ankita
description Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma. Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST. Settings and Design: This was a retrospective study. Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment. Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method. Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P < 0.0001), palliative intent of treatment (P < 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS. Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.
doi_str_mv 10.4103/jcrt.JCRT_854_19
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2501851674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A655948365</galeid><sourcerecordid>A655948365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</originalsourceid><addsrcrecordid>eNp1kt1vFCEUxYnR2G313SdD4osvs8LAfODbduNnakxMfSYMc2eW7QyswOza_75MtjXVrOEBAr9z77nkIPSKkiWnhL3bah-XX9c_rmVdcEnFE7SgQtQZp6x-ihZEVCyjvM7P0HkIW0KKKs_r5-iMsSpnlJMF2n9Tg-mtshHvwJvdBrwasAW_Bxw2oOIGx2l0Hh9MOiqrhttgAnYd3itv3BTwzrveuhCNxp3S0fnwHq9wMLYfIDM2PcQpGpeUGH7PPcBqeIGedWoI8PJ-v0A_P364Xn_Orr5_-rJeXWWaC2qznBDRckWVaJuyZYTmbRqp6sqcEt7UvIVKkIqVRa2armpqoJpABVXOQQlaCHaB3h7rJpe_JghRjiZoGAZlIZmXeUFoXdCy4gl98w-6dZNPtmeK5alHIR5RvRpAGtu56JWei8pVWSSiTm4SlZ2gerDz7zoLnUnXf_HLE3xaLYxGnxSQo0B7F4KHTu68GZW_lZTIORpyjoZ8FI0keX0_39SM0P4RPGQhAZdH4OCGCD7cDNMBvEzsjXWH_xZOD6V8SBG7A4KFzM0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532658594</pqid></control><display><type>article</type><title>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</title><source>Publicly Available Content Database</source><creator>Sharma, Mohit ; Puj, Ketul ; Salunke, Abhijeet ; Pandya, Shashank ; Gandhi, Jahnavi ; Parikh, Ankita</creator><creatorcontrib>Sharma, Mohit ; Puj, Ketul ; Salunke, Abhijeet ; Pandya, Shashank ; Gandhi, Jahnavi ; Parikh, Ankita</creatorcontrib><description>Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma. Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST. Settings and Design: This was a retrospective study. Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment. Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method. Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P &lt; 0.0001), palliative intent of treatment (P &lt; 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS. Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/jcrt.JCRT_854_19</identifier><identifier>PMID: 33723140</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Adult ; Care and treatment ; Female ; Genetic disorders ; Humans ; Male ; Margins of Excision ; Medical prognosis ; Middle Aged ; Multivariate analysis ; Neoplasm Metastasis ; Nerve Sheath Neoplasms - genetics ; Nerve Sheath Neoplasms - pathology ; Nerve Sheath Neoplasms - surgery ; Nervous system tumors ; Neurological disorders ; Palliative Care - methods ; Patient outcomes ; Prognosis ; Retrospective Studies ; Risk Factors ; Sarcoma ; Survival analysis ; Survival Rate ; Treatment Outcome ; Tumors</subject><ispartof>Journal of cancer research and therapeutics, 2021-01, Vol.17 (1), p.106-113</ispartof><rights>COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd.</rights><rights>2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</citedby><cites>FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2532658594?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,37012,44589</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33723140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharma, Mohit</creatorcontrib><creatorcontrib>Puj, Ketul</creatorcontrib><creatorcontrib>Salunke, Abhijeet</creatorcontrib><creatorcontrib>Pandya, Shashank</creatorcontrib><creatorcontrib>Gandhi, Jahnavi</creatorcontrib><creatorcontrib>Parikh, Ankita</creatorcontrib><title>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma. Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST. Settings and Design: This was a retrospective study. Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment. Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method. Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P &lt; 0.0001), palliative intent of treatment (P &lt; 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS. Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.</description><subject>Adult</subject><subject>Care and treatment</subject><subject>Female</subject><subject>Genetic disorders</subject><subject>Humans</subject><subject>Male</subject><subject>Margins of Excision</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Neoplasm Metastasis</subject><subject>Nerve Sheath Neoplasms - genetics</subject><subject>Nerve Sheath Neoplasms - pathology</subject><subject>Nerve Sheath Neoplasms - surgery</subject><subject>Nervous system tumors</subject><subject>Neurological disorders</subject><subject>Palliative Care - methods</subject><subject>Patient outcomes</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Sarcoma</subject><subject>Survival analysis</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kt1vFCEUxYnR2G313SdD4osvs8LAfODbduNnakxMfSYMc2eW7QyswOza_75MtjXVrOEBAr9z77nkIPSKkiWnhL3bah-XX9c_rmVdcEnFE7SgQtQZp6x-ihZEVCyjvM7P0HkIW0KKKs_r5-iMsSpnlJMF2n9Tg-mtshHvwJvdBrwasAW_Bxw2oOIGx2l0Hh9MOiqrhttgAnYd3itv3BTwzrveuhCNxp3S0fnwHq9wMLYfIDM2PcQpGpeUGH7PPcBqeIGedWoI8PJ-v0A_P364Xn_Orr5_-rJeXWWaC2qznBDRckWVaJuyZYTmbRqp6sqcEt7UvIVKkIqVRa2armpqoJpABVXOQQlaCHaB3h7rJpe_JghRjiZoGAZlIZmXeUFoXdCy4gl98w-6dZNPtmeK5alHIR5RvRpAGtu56JWei8pVWSSiTm4SlZ2gerDz7zoLnUnXf_HLE3xaLYxGnxSQo0B7F4KHTu68GZW_lZTIORpyjoZ8FI0keX0_39SM0P4RPGQhAZdH4OCGCD7cDNMBvEzsjXWH_xZOD6V8SBG7A4KFzM0</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Sharma, Mohit</creator><creator>Puj, Ketul</creator><creator>Salunke, Abhijeet</creator><creator>Pandya, Shashank</creator><creator>Gandhi, Jahnavi</creator><creator>Parikh, Ankita</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20210101</creationdate><title>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</title><author>Sharma, Mohit ; Puj, Ketul ; Salunke, Abhijeet ; Pandya, Shashank ; Gandhi, Jahnavi ; Parikh, Ankita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Care and treatment</topic><topic>Female</topic><topic>Genetic disorders</topic><topic>Humans</topic><topic>Male</topic><topic>Margins of Excision</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Neoplasm Metastasis</topic><topic>Nerve Sheath Neoplasms - genetics</topic><topic>Nerve Sheath Neoplasms - pathology</topic><topic>Nerve Sheath Neoplasms - surgery</topic><topic>Nervous system tumors</topic><topic>Neurological disorders</topic><topic>Palliative Care - methods</topic><topic>Patient outcomes</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Sarcoma</topic><topic>Survival analysis</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Mohit</creatorcontrib><creatorcontrib>Puj, Ketul</creatorcontrib><creatorcontrib>Salunke, Abhijeet</creatorcontrib><creatorcontrib>Pandya, Shashank</creatorcontrib><creatorcontrib>Gandhi, Jahnavi</creatorcontrib><creatorcontrib>Parikh, Ankita</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Mohit</au><au>Puj, Ketul</au><au>Salunke, Abhijeet</au><au>Pandya, Shashank</au><au>Gandhi, Jahnavi</au><au>Parikh, Ankita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>17</volume><issue>1</issue><spage>106</spage><epage>113</epage><pages>106-113</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Context: Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft-tissue sarcoma. Aims: The aim of this study was to analyze various prognostic factors and treatment outcome of patients with MPNST. Settings and Design: This was a retrospective study. Subjects and Methods: Ninety-two patients, who presented with MPNST at a tertiary care cancer center from 2011 to 2018, were included in this study. The median follow-up of all living patients was 33 months. Neurofibromatosis 1 (NF1) was seen in 12 (13%) patients. Sixty (65.2%) patients received curative-intent treatment. Statistical Analysis Used: Kaplan-Meier method was used for survival analysis. Log-rank test was used for univariate analysis, and multivariate analysis was done by Cox proportional hazard ratio method. Results: The 5-year overall survival (OS) of all patients was 47.2% and the 5-year disease-free survival (DFS) of operated patients was 41.5%. On univariate analysis, association with NF1 (P = 0.009), grade (P = 0.017), and margin status (P = 0.002) had a significant effect on DFS, whereas association with NF1 (P = 0.025), metastatic disease on presentation (P &lt; 0.0001), palliative intent of treatment (P &lt; 0.0001), grade (P = 0.049), and margin status (P = 0.036) had a significant effect on OS. On multivariate analysis for patients who were treated with curative-intent treatment, grade (P = 0.015), and margin status (P = 0.028) had a significant effect on DFS, whereas association with NF1 (P = 0.00026) and location of tumor (P = 0.040) had a significant effect on OS. Conclusions: The presence of distant metastasis, palliative intent of treatment, association with NF1, location of the tumor in the head and neck, high tumor grade, and positive margin status were the risk factors associated with poor survival for the patients with MPNST. Wide local excision with negative resection margin is the highly recommended treatment.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>33723140</pmid><doi>10.4103/jcrt.JCRT_854_19</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-1482
ispartof Journal of cancer research and therapeutics, 2021-01, Vol.17 (1), p.106-113
issn 0973-1482
1998-4138
language eng
recordid cdi_proquest_miscellaneous_2501851674
source Publicly Available Content Database
subjects Adult
Care and treatment
Female
Genetic disorders
Humans
Male
Margins of Excision
Medical prognosis
Middle Aged
Multivariate analysis
Neoplasm Metastasis
Nerve Sheath Neoplasms - genetics
Nerve Sheath Neoplasms - pathology
Nerve Sheath Neoplasms - surgery
Nervous system tumors
Neurological disorders
Palliative Care - methods
Patient outcomes
Prognosis
Retrospective Studies
Risk Factors
Sarcoma
Survival analysis
Survival Rate
Treatment Outcome
Tumors
title Malignant peripheral nerve sheath tumor with analysis of various prognostic factors: A single-institutional experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A18%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Malignant%20peripheral%20nerve%20sheath%20tumor%20with%20analysis%20of%20various%20prognostic%20factors:%20A%20single-institutional%20experience&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Sharma,%20Mohit&rft.date=2021-01-01&rft.volume=17&rft.issue=1&rft.spage=106&rft.epage=113&rft.pages=106-113&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/jcrt.JCRT_854_19&rft_dat=%3Cgale_proqu%3EA655948365%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491n-2009d4a1a9db6d3012d9737f62104b84de79073658abf7b8e1c0e7e724ea91593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532658594&rft_id=info:pmid/33723140&rft_galeid=A655948365&rfr_iscdi=true